Clinical Trials List
Protocol NumberCTNO155X2101
Completed
2019-03-01 - 2025-12-31
Phase I
Recruiting1
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- James Chih-Hsin Yang 無
- 廖斌志 無
- 徐偉勛 無
- 林昭文 無
- Chong-Jen Yu 無
- CHAO-CHI HO CHAO-CHI HO 無
- 楊景堯 無
- Wei-Wu Chen 無
- JIN-YUAN SHIH 無
- 廖唯昱 無
- 朱筱桑 無
- Jih-Hsiang Lee 無
- 蔡子修 無
- 許嘉林 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10-15 participants
-
Global
135 participants
